Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > IONC Brands 35 million in annual Sales at a 10M current mark
View:
Post by Acura001 on Oct 05, 2021 3:53am

IONC Brands 35 million in annual Sales at a 10M current mark

C.IONC Current SP is 0.095 cents. Undervalued / watchlist
 
Record Q2-2021 sales revenues of $8.3M and realized $1.3M in gross profit representing a 16% gross margin for the second quarter 2021, a 1.2% decline on quarter-on-quarter growth due to our combined B2B wholesale business and entrance into the sales of lower margin flower sales compared to our concentrate segments.
 
Record H1 sales revenues of $12.5M which exceeds the entire fiscal year of 2020 revenues by $3.5M, representing a 40% increase in revenue YTD
 
The Company maintains its target on baseline revenues of over $28 million for annual 2021.
 
Improved balance sheet through the conversion of $12.9 million in secured debt to preferred equity
Be the first to comment on this post